Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

50.0%

% of PPH's 25 holdings also in XPH

29.3%

% of XPH's 41 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in XPH
Overlap
ZOETIS INC 5.2% 4.7% 4.7%
MERCK & CO. INC. 5.4% 4.2% 4.2%
ELI LILLY & CO 5.2% 4.0% 4.0%
VIATRIS, INC. 3.8% 3.8% 3.8%
JOHNSON & JOHNSON 7.5% 3.8% 3.8%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
NOVO-NORDISK A/S-SPONS ADR 5.9%
ABBVIE INC 5.6%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 5.3%
ASTRAZENECA PLC-SPONS ADR 5.0%
SANOFI-AVENTIS-ADR 4.7%
NOVARTIS AG-ADR 4.7%
GLAXOSMITHKLINE PLC-SPON ADR 4.4%
AMERISOURCEBERGEN CORP 4.2%
MCKESSON CORP 4.2%
JOHNSON & JOHNSON 3.8%
PPH Underweight Relative to XPH
REVANCE THERAPEUTICS INC -6.0%
REATA PHARMACEUTICALS, INC. CLASS A -5.5%
AXSOME THERAPEUTICS, INC. -3.7%
ROYALTY PHARMA PLC CLASS A -3.6%
PERRIGO CO -3.4%
CATALENT INC -3.4%
INTRA-CELLULAR THERAPIES INC -3.0%
CASSAVA SCIENCES, INC. -3.0%
AMYLYX PHARMACEUTICALS, INC. -2.8%
PROVENTION BIO, INC. -2.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY